Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Brian Smith

Showing results (151-160 of 280) with videos related to

Pageof 28
Sort By:
The Pediatric Infectious Disease Journal|July 18, 2020
Dosing of Antimicrobials in the Neonatal Intensive Care Unit: Does Clinical Practice Reflect Pharmacokinetics-based Recommendations?Ashley Stark, Julie Childers, Morgan England, et al.
Archives of Pediatrics & Adolescent Medicine|December 10, 2009
Safety and transparency of pediatric drug trialsDaniel K Benjamin, P Brian Smith, M Jessica M Sun, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|October 9, 2020
Association between neonatal intensive care unit medication safety practices, adverse events, and deathLaura E Miller, Chris DeRienzo, P Brian Smith, et al.
Hypertension (Dallas, Tex. : 1979)|March 12, 2008
Pediatric antihypertensive trial failures: analysis of end points and dose rangeDaniel K Benjamin, P Brian Smith, Pravin Jadhav, et al.
Pediatrics|December 17, 2014
Anaerobic antimicrobial therapy after necrotizing enterocolitis in VLBW infantsJulie Autmizguine, Christoph P Hornik, Daniel K Benjamin, et al.
The Pediatric Infectious Disease Journal|September 17, 2015
Cefepime and Ceftazidime Safety in Hospitalized InfantsChristopher J Arnold, Jessica Ericson, Nathan Cho, et al.
The Pediatric Infectious Disease Journal|March 12, 2015
No survival benefit with empirical vancomycin therapy for coagulase-negative staphylococcal bloodstream infections in infantsJessica E Ericson, Joshua Thaden, Heather R Cross, et al.
JAMA Pediatrics|December 8, 2015
Postnatal Cytomegalovirus Infection and the Risk for Bronchopulmonary DysplasiaMatthew S Kelly, Daniel K Benjamin, Karen M Puopolo, et al.
Neonatology|October 7, 2020
Pharmacoepidemiology of Furosemide in the Neonatal Intensive Care UnitElizabeth J Thompson, Daniel K Benjamin, Rachel G Greenberg, et al.
Antimicrobial Agents and Chemotherapy|March 12, 2014
Developmental pharmacokinetics of piperacillin and tazobactam using plasma and dried blood spots from infantsMichael Cohen-Wolkowiez, Kevin M Watt, Chenguang Zhou, et al.
Pageof 28

Showing results (151-160 of 280) with videos related to

Sort By:
Pageof 28
The Pediatric Infectious Disease Journal|July 18, 2020
Dosing of Antimicrobials in the Neonatal Intensive Care Unit: Does Clinical Practice Reflect Pharmacokinetics-based Recommendations?Ashley Stark, Julie Childers, Morgan England, et al.
Archives of Pediatrics & Adolescent Medicine|December 10, 2009
Safety and transparency of pediatric drug trialsDaniel K Benjamin, P Brian Smith, M Jessica M Sun, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|October 9, 2020
Association between neonatal intensive care unit medication safety practices, adverse events, and deathLaura E Miller, Chris DeRienzo, P Brian Smith, et al.
Hypertension (Dallas, Tex. : 1979)|March 12, 2008
Pediatric antihypertensive trial failures: analysis of end points and dose rangeDaniel K Benjamin, P Brian Smith, Pravin Jadhav, et al.
Pediatrics|December 17, 2014
Anaerobic antimicrobial therapy after necrotizing enterocolitis in VLBW infantsJulie Autmizguine, Christoph P Hornik, Daniel K Benjamin, et al.
The Pediatric Infectious Disease Journal|September 17, 2015
Cefepime and Ceftazidime Safety in Hospitalized InfantsChristopher J Arnold, Jessica Ericson, Nathan Cho, et al.
The Pediatric Infectious Disease Journal|March 12, 2015
No survival benefit with empirical vancomycin therapy for coagulase-negative staphylococcal bloodstream infections in infantsJessica E Ericson, Joshua Thaden, Heather R Cross, et al.
JAMA Pediatrics|December 8, 2015
Postnatal Cytomegalovirus Infection and the Risk for Bronchopulmonary DysplasiaMatthew S Kelly, Daniel K Benjamin, Karen M Puopolo, et al.
Neonatology|October 7, 2020
Pharmacoepidemiology of Furosemide in the Neonatal Intensive Care UnitElizabeth J Thompson, Daniel K Benjamin, Rachel G Greenberg, et al.
Antimicrobial Agents and Chemotherapy|March 12, 2014
Developmental pharmacokinetics of piperacillin and tazobactam using plasma and dried blood spots from infantsMichael Cohen-Wolkowiez, Kevin M Watt, Chenguang Zhou, et al.
Pageof 28